Get the Stockscreener App
24.91
0.82%
-0.205
After Hours:
24.91
Caredx Inc stock is traded at $24.91, with a volume of 635.80K.
It is down -0.82% in the last 24 hours and up +11.26% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
See More
Previous Close:
$25.11
Open:
$25.39
24h Volume:
635.80K
Relative Volume:
0.77
Market Cap:
$1.35B
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-15.97
EPS:
-1.56
Net Cash Flow:
$1.22M
1W Performance:
+11.35%
1M Performance:
+11.26%
6M Performance:
+56.27%
1Y Performance:
+158.94%
1-Day Range:
$24.55
$25.85
1-Week Range:
$22.00
$25.85
52-Week Range:
$7.42
$34.84
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
24.91 | 1.35B | 312.78M | -143.56M | 1.22M | -1.56 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
Wall Street Analysts Predict a 49.89% Upside in CareDx (CDNA): Here's What You Should Know - Yahoo Finance
CareDx Inc (CDNA) Trading 6.16% Higher on Oct 2 - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Raises Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA) - MSN
CareDx Inc (CDNA) Trading 1.84% Higher on Nov 19 - GuruFocus.com
Are Medical Stocks Lagging CareDx (CDNA) This Year? - MSN
CareDx, Inc (NASDAQ:CDNA) Receives $29.60 Consensus Price Target from Analysts - MarketBeat
Sumitomo Mitsui Trust Group Inc. Reduces Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Los Angeles Capital Management LLC Cuts Stock Position in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
CareDx Inc (CDNA) Shares Up 4.16% on Nov 13 - GuruFocus.com
CDNACareDx, Inc. Latest Stock News & Market Updates - StockTitan
CareDx to Participate in Upcoming Investor Conferences - Yahoo Finance
CareDx, Inc (NASDAQ:CDNA) Q3 2024 Earnings Call Transcript - MSN
Nikko Asset Management Americas, Inc. Reduces Stake in CareDx Inc - GuruFocus.com
(CDNA) On The My Stocks Page - Stock Traders Daily
ARK Investment Management LLC Decreases Holdings in CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Accelerated Testing Volume Lifted CareDx (CDNA) in Q3 - Insider Monkey
24,998 Shares in CareDx, Inc (NASDAQ:CDNA) Bought by Hanseatic Management Services Inc. - MarketBeat
CareDx Inc (CDNA) Q3 2024 Earnings: Revenue Hits $82.9M, Beating Estimates; GAAP EPS Loss at $0.14 - GuruFocus.com
CareDx Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
CareDx stock dips 20%, BTIG sees value with revenue growth set to accelerate in 2025 - Investing.com Australia
CareDx (NASDAQ:CDNA) Shares Gap Down on Analyst Downgrade - MarketBeat
CareDx (NASDAQ:CDNA) Given New $35.00 Price Target at BTIG Research - MarketBeat
Earnings call: CareDx sees robust growth in Q3, raises FY 2024 outlook - Investing.com Australia
CareDx (NASDAQ:CDNA) Announces Quarterly Earnings Results - MarketBeat
Earnings call: CareDx sees robust growth in Q3, raises FY 2024 outlook By Investing.com - Investing.com South Africa
Sumitomo Mitsui Trust Group's Strategic Reduction in CareDx Inc Holdings - GuruFocus.com
CareDx price target lowered to $35 from $40 at BTIG - TipRanks
The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 26% - Simply Wall St
CareDx Inc (CDNA) Q3 2024 Earnings Call Highlights: Robust Reven - GuruFocus.com
CareDx Inc (CDNA) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
CareDx Inc (CDNA) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... - Yahoo Finance
CareDx Inc. Reports Solid Growth and Raises Guidance - TipRanks
Caredx Inc earnings beat by $0.39, revenue topped estimates - Investing.com
CareDx: Q3 Earnings Snapshot - San Antonio Express-News
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance - The Bakersfield Californian
CareDx (CDNA) Set to Announce Earnings on Monday - Defense World
Assenagon Asset Management S.A. Sells 100,518 Shares of CareDx, Inc (NASDAQ:CDNA) - MarketBeat
Jing Huang Joins CareDx as Chief Data and AI Officer - MPO-mag
CareDx (CDNA) Scheduled to Post Quarterly Earnings on Monday - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Shares Acquired by Allspring Global Investments Holdings LLC - MarketBeat
CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - AccessWire
HC Wainwright Issues Positive Outlook for CareDx Earnings - MarketBeat
CareDx and Dovetail Genomics announce HLA typing partnershi - Investing.com
CareDx and Dovetail Genomics announce HLA typing partnershi By Investing.com - Investing.com Australia
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):